Prenetics, a genomics-driven health sciences company, and Dennis Lo, a renowned scientist, agreed to form Insighta, a joint venture which aims to revolutionize multi-cancer early detection, in a $200m deal. "I am genuinely exhilarated to be at the forefront of such a ground-breaking new technology. Joining forces with Danny Yeung and Prenetics is particularly inspiring - a joint venture that not only ensures robust capital resources, strong management but also a mutual vision of global health transformation. We are driven by the profound potential to save countless lives, and together, we will make a significant stride towards a healthier future for all," Dennis Lo.